Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-fluorouracil vs capecitabine plus cisplatin with IMRT in locally advanced nasopharyngeal carcinoma
ChiCTR-OIQ-16008412Phase 2Not yet recruiting
- Sponsor
- The Second People's Hospital of Neijiang
- Start
- Jun 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in nasopharyngeal carcinoma (NPC) comparing 5-fluorouracil + cisplatin CCRT with capecitabine + cisplatin CCRT (2 arms). Primary endpoint: Overall survival. Planned start Jun 2016; status: not yet recruiting.
02
Drugs
fluorouracilcapecitabinecisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-OIQ-16008412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIQ-16008412.